Journal article
Advancing genetic testing for deafness with genomic technology
Journal of medical genetics, Vol.50(9), pp.627-634
09/2013
DOI: 10.1136/jmedgenet-2013-101749
PMCID: PMC3887546
PMID: 23804846
Abstract
Non-syndromic hearing loss (NSHL) is the most common sensory impairment in humans. Until recently its extreme genetic heterogeneity precluded comprehensive genetic testing. Using a platform that couples targeted genomic enrichment (TGE) and massively parallel sequencing (MPS) to sequence all exons of all genes implicated in NSHL, we tested 100 persons with presumed genetic NSHL and in so doing established sequencing requirements for maximum sensitivity and defined MPS quality score metrics that obviate Sanger validation of variants. We examined DNA from 100 sequentially collected probands with presumed genetic NSHL without exclusions due to inheritance, previous genetic testing, or type of hearing loss. We performed TGE using post-capture multiplexing in variable pool sizes followed by Illumina sequencing. We developed a local Galaxy installation on a high performance computing cluster for bioinformatics analysis. To obtain maximum variant sensitivity with this platform 3.2-6.3 million total mapped sequencing reads per sample were required. Quality score analysis showed that Sanger validation was not required for 95% of variants. Our overall diagnostic rate was 42%, but this varied by clinical features from 0% for persons with asymmetric hearing loss to 56% for persons with bilateral autosomal recessive NSHL. These findings will direct the use of TGE and MPS strategies for genetic diagnosis for NSHL. Our diagnostic rate highlights the need for further research on genetic deafness focused on novel gene identification and an improved understanding of the role of non-exonic mutations. The unsolved families we have identified provide a valuable resource to address these areas.
Details
- Title: Subtitle
- Advancing genetic testing for deafness with genomic technology
- Creators
- A Eliot Shearer - Department of Otolaryngology-Head and Neck Surgery, Molecular Otolaryngology & Renal Research Labs, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USAE Ann Black-ZiegelbeinMichael S HildebrandRobert W EppsteinerHarini RaviSwati JoshiAngelica C GuiffreChristina M SloanScott HappeSusanna D HowardBarbara NovakAdam P DelucaKyle R TaylorTodd E ScheetzTerry A BraunThomas L CasavantWilliam J KimberlingEmily M LeproustRichard J H Smith
- Resource Type
- Journal article
- Publication Details
- Journal of medical genetics, Vol.50(9), pp.627-634
- DOI
- 10.1136/jmedgenet-2013-101749
- PMID
- 23804846
- PMCID
- PMC3887546
- NLM abbreviation
- J Med Genet
- ISSN
- 1468-6244
- eISSN
- 1468-6244
- Publisher
- England
- Grant note
- DC002842 / NIDCD NIH HHS 1F30DC011674 / NIDCD NIH HHS R01 DC003544 / NIDCD NIH HHS R01 DC012049 / NIDCD NIH HHS DC012049 / NIDCD NIH HHS F30 DC011674 / NIDCD NIH HHS R01 DC002842 / NIDCD NIH HHS DC003544 / NIDCD NIH HHS
- Language
- English
- Date published
- 09/2013
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Electrical and Computer Engineering; Molecular Physiology and Biophysics; Anatomy and Cell Biology; Stead Family Department of Pediatrics; Iowa Neuroscience Institute; Center for Bioinformatics and Computational Biology; Otolaryngology; Internal Medicine; Ophthalmology and Visual Sciences
- Record Identifier
- 9983979964402771
Metrics
35 Record Views